December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,074.68 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
News headline image
2 Top Dividend Stocks for Growth-Oriented Investors ↗
Who says you have to choose between the two? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant? ↗
The obesity drug producer has taken some hits throughout the past year, but it is beginning to punch back. 
Via The Motley Fool
Topics Government
News headline image
2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026? ↗
Many other drugmakers are attempting to break this duopoly, but this may not happen anytime soon. 
Via The Motley Fool
News headline image
3 Top Dividend Stocks to Buy in November ↗
November is a great month to be thankful for opportunities to invest in these fantastic companies. 
Via The Motley Fool
Topics Bonds Economy
Eli Lilly Joins Tech Players In The $1T Market Capitalization Club ↗
The company’s GLP-1 drugs, Zepbound and Mounjaro, have driven investor appetite and pushed its share price by about 40% this year. 
Via Stocktwits
News headline image
How To Play Eli Lilly Stock As It Hits A Much-Anticipated Milestone? ↗
Eli Lilly stock has already rallied 70% in less than four months. 
Via Talk Markets
News headline image
A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Eli Lilly Stock Just Joined the $1 Trillion Club. Should You Buy LLY Here?
Eli Lilly stock inches higher as the company joins the coveted trillion-dollar club. Citi analysts believe LLY shares will push meaningfully higher in 2026. 
Via Barchart.com
Topics Government
News headline image
Eli Lilly Breaks $1 Trillion Barrier, A First For The Healthcare Industry ↗
Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as demand for its weight-loss drugs continues to surge. 
Via Talk Markets
News headline image
Eli Lilly Stock Is Rising Today: Here&#39;s What You Need To Know ↗
Eli Lilly and Co (NYSE:LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access. 
Via Benzinga
News headline image
The AI Valuation Conundrum: Is the Market Inflating a Bubble or Fueling a Revolution?
Concerns are mounting across financial markets regarding a potential "AI bubble," as sky-high valuations for technology companies, particularly those focused on artificial intelligence, trigger... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
News headline image
Eli Lilly Becomes First Pharma To Join $1 Trillion Club Alongside Nvidia, Apple, Others ↗
Eli Lilly became the first health care company to top $1 trillion in market capitalization on Friday. 
Via Investor's Business Daily
News headline image
Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs
Eli Lilly (LLY) just became the first healthcare company to join the $1 trillion market cap club. Shares are trading at a new all-time high on Friday, Nov. 21. The stock is up 40% in the past year and... 
Via Barchart.com
News headline image
Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Supernus Pharmaceuticals (NASDAQ:SUPN) and... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
What's Going On With Novo Nordisk Stock? ↗
The management team conducted a cost-cutting effort that is likely to result in a more efficient business. 
Via The Motley Fool
News headline image
KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds
KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a... 
Via MarketMinute
News headline image
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly? ↗
Novo Nordisk just addressed a problem that has prevented some from taking these drugs. 
Via The Motley Fool
News headline image
Correction and Clarification: Trifecta and Edward Fruitman, M.D., Do Not Maintain Any Contractual Relationship or Product Preference With Eli Lilly or LillyDirect®
November 20, 2025 -- The organization reiterates it has no partnership with Lilly and does not endorse or favor Eli Lilly products, including Zepbound®, in its weight-loss and medical services. 
Via 24-7 Press Release
News headline image
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗
Via MarketBeat
News headline image
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Down 45% Year-to-Date, Novo Nordisk Ignites a Price War ↗
Via MarketBeat
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
This Blue-Chip Stock Is a Heavy Weight in Weight-Loss Drugs
Eli Lilly (LLY) stands out for its diversified pharmaceutical portfolio, robust pipeline, and strategic acquisitions that are fueling growth. LLY has strong technical momentum and is trading at new... 
Via Barchart.com
Topics Intellectual Property
News headline image
Eli Lilly on "Stock Split Watch": A Deep Dive into a Pharmaceutical Giant's Future
Indianapolis, IN – November 19, 2025 – Eli Lilly and Company (NYSE: LLY), the pharmaceutical titan, finds itself at the epicenter of market speculation, firmly placed on "stock split watch" as its... 
Via MarketMinute
News headline image
Eli Lilly Unusual Options Activity For November 19 ↗
 
Via Benzinga
News headline image
Stock Split Watch: Could This Unstoppable Growth Stock Be Next? ↗
Don't wait for a stock split to buy the stock, though. 
Via The Motley Fool
News headline image
Healthcare Rotation Underway: 3 Stocks Leading the Charge ↗
Via MarketBeat
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
These stocks both have advanced in the double-digits in recent months. 
Via The Motley Fool
News headline image
2 High-Flying Stocks with Exciting Potential and 1 We Find Risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.